$HROW News

Harrow Inc (NASDAQ:HROW): An Affordable Growth Play Combining Rapid Expansion with Reasonable Valuation

Harrow: Demand Keeps It Interesting, Valuation Keeps It A Hold

Harrow, Inc. 2026 Q1 - Results - Earnings Call Presentation

Cantor Fitzgerald Maintains Overweight on Harrow, Lowers Price Target to $88

Harrow, Inc. (HROW) Q1 2026 Earnings Call Transcript

Transcript: Harrow Q1 2026 Earnings Conference Call

Harrow (HROW) Reports Q1 Loss, Lags Revenue Estimates

Harrow Inc (NASDAQ:HROW) Q1 2026 Results Miss Estimates, Revenue and Earnings Fall Short

Harrow Announces First Quarter 2026 Financial Results

Harrow Affirms FY2026 Sales Guidance of $350.000M-$365.000M vs $351.380M Est

Harrow Sees Q2 Sales $71.000M-$81.000M vs $76.647M Est

Harrow Q1 EPS $(0.74) Misses $(0.39) Estimate, Sales $44.203M Miss $52.420M Estimate

Is Harrow (HROW) Pricing Reflect Its 65.5% One Year Surge And DCF Outlook

Harrow Inc (NASDAQ:HROW) Screens as a Strong Growth Stock with a Bullish Technical Setup

Relay Therapeutics, Inc. (RLAY) Reports Q1 Loss, Lags Revenue Estimates

Analysts Estimate Harrow (HROW) to Report a Decline in Earnings: What to Look Out for

Is Harrow, Inc. (HROW) A Good Stock To Buy Now?

Harrow To Report First Quarter 2026 Financial Results After Market Close on May 11, 2026

Harrow: Now Is The Buy Time

Harrow Inc (NASDAQ:HROW) Presents a Compelling Case for Affordable Growth